Abstract |
Several studies have shown functional improvements, neuroprotective, and neuroregenerative effects after mesenchymal stem cells transplantation to parkinsonian animal models. However, questions remain about the safety, feasibility, and long-term efficacy of this approach. In this study, we investigated migration, therapeutic, tumorigenesis, and epileptogenic effects of human umbilical cord mesenchymal stromal cells (HUMSCs) 1 year after transplantation into rotenone-induced hemiparkinsonian rats. Our data indicated that DiI-labeled HUMSCs migrated in the lesioned hemisphere, from corpus striatum (CPu) to substantia nigra. By integrating with host cells and differentiating into NSE, GFAP, Nestin, and tyrosine hydroxylase-positive cells, HUMSCs prevented 48.4% dopamine neurons from degeneration and 56.9% dopamine terminals from loss, both correlating with improvement of apomorphine-induced rotations. The CD50 and CD97 value of pentylenetetrazol and semiquantitative immunohistochemical analysis of proliferating cell nuclear antigen ( PCNA), β-catenin, C-myc, and NF-κB expression showed no significant difference between HUMSCs transplanted and untransplanted groups, whereas the expressions of Bcl-2 and P53 in the grafted CPu were upregulated by 281% and 200% compared to ungrafted CPu. The results of this long-term study suggest that HUMSCs transplantation, 1 of the most potential treatments for Parkinson's disease, is an effective and safe approach.
|
Authors | Nian Xiong, Xuebing Cao, Zhentao Zhang, Jinsha Huang, Chunnuan Chen, Zhaowen Zhang, Min Jia, Jing Xiong, Zhihou Liang, Shenggang Sun, Zhicheng Lin, Tao Wang |
Journal | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
(Biol Blood Marrow Transplant)
Vol. 16
Issue 11
Pg. 1519-29
(Nov 2010)
ISSN: 1523-6536 [Electronic] United States |
PMID | 20542126
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2010 American Society for Blood and Marrow Transplantation. All rights reserved. |
Chemical References |
- Adaptor Proteins, Signal Transducing
- Carbocyanines
- Grap protein, human
- Intermediate Filament Proteins
- NES protein, human
- Neoplasm Proteins
- Nerve Tissue Proteins
- Nes protein, rat
- Nestin
- Rotenone
- 3,3'-dioctadecylindocarbocyanine
- Tyrosine 3-Monooxygenase
- Phosphopyruvate Hydratase
- Apomorphine
- Pentylenetetrazole
|
Topics |
- Adaptor Proteins, Signal Transducing
(metabolism)
- Animals
- Apomorphine
(pharmacology)
- Brain
(drug effects)
- Carbocyanines
(metabolism)
- Cell Differentiation
(physiology)
- Cell Movement
(physiology)
- Corpus Striatum
(cytology, metabolism)
- Dose-Response Relationship, Drug
- Epilepsy
(chemically induced)
- Female
- Humans
- Intermediate Filament Proteins
(metabolism)
- Locomotion
(drug effects)
- Mesenchymal Stem Cell Transplantation
(adverse effects, methods)
- Mesenchymal Stromal Cells
(cytology, metabolism)
- Neoplasm Proteins
(metabolism)
- Nerve Tissue Proteins
(metabolism)
- Nestin
- Neurons
(cytology, metabolism)
- Parkinsonian Disorders
(chemically induced, therapy)
- Pentylenetetrazole
(pharmacology)
- Phosphopyruvate Hydratase
(metabolism)
- Rats
- Rats, Sprague-Dawley
- Rotation
- Rotenone
(pharmacology)
- Staining and Labeling
(methods)
- Substantia Nigra
(cytology, metabolism)
- Treatment Outcome
- Tyrosine 3-Monooxygenase
(metabolism)
- Umbilical Cord
(cytology)
- Ventral Tegmental Area
(cytology)
|